title: How to keep your integrity when performing sponsored (imaging) trials.
abstract: The broadening of imaging capabilities and the increasing capacity of imaging to quantitate biologic processes has increased industry interest in using imaging methods in new drug development. Investigators participating in industry-sponsored trials should be aware of how such trials differ from investigator-initiated, grant-funded research. In particular, investigators should be cognizant of possible ethical conflicts in the care of patients, the development and analysis of data, and issues related to the dissemination of results.
authors.affiliation: Department of Radiology, Antwerp University Hospital & University of Antwerp, Antwerp, Belgium. paul.parizel@ua.ac.be
authors.forename: Paul M
authors.initials: PM
authors.lastname: Parizel
authors.forename: Wim
authors.initials: W
authors.lastname: van Hecke
mesh_terms: D002986:Clinical Trials as Topic / Q000941:ethics*; D016265:Conflict of Interest; D003952:Diagnostic Imaging / Q000706:statistics & numerical data*; D010820:Physicians / Q000941:ethics*; D011871:Radiology / Q000941:ethics*; D012109:Research Support as Topic / Q000941:ethics*; D014481:United States